Combination immunotherapy for the treatment of cancer
摘要
Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-I, etc.) are demonstrated herein to be useful for the treatment of tumors.
申请公布号
AU2010303149(A1)
申请公布日期
2012.04.26
申请号
AU20100303149
申请日期
2010.09.30
申请人
MEMORIAL SLOAN-KETTERING CANCER CENTER;BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
